Current Cancer Drug Targets

杂志介绍

Current Cancer Drug Targets杂志介绍

《Current Cancer Drug Targets》是一本以English为主的未开放获取国际优秀期刊，中文名称当前的抗癌药物靶点，本刊主要出版、报道医学-ONCOLOGY领域的研究动态以及在该领域取得的各方面的经验和科研成果，介绍该领域有关本专业的最新进展，探讨行业发展的思路和方法，以促进学术信息交流，提高行业发展。该刊已被国际权威数据库SCIE收录，为该领域相关学科的发展起到了良好的推动作用，也得到了本专业人员的广泛认可。该刊最新影响因子为2.3，最新CiteScore 指数为5.4。

本刊近期中国学者发表的论文主要有：

• Combined Immunotherapy and Targeted Therapies for Cancer Treatment: Recent Advances and Future Perspectives

  Author: Zhang, Yan; Li, Yafei; Fu, Qiuxia; Han, Zhiqiang; Wang, Daijie; Shinge, Shafiu A. Umar; Muluh, Tobias Achu; Lu, Xiaohong

• Phosphoserine Aminotransferase 1: A Metabolic Enzyme Target of Cancers

  Author: Yang, Xue; Li, Chaojie; Chen, Yuping

• Combinatorial Application of Papain and CD66B for Isolating Glioma-Associated Neutrophils

  Author: Xu, Xing; Yang, Yongchang; Liu, Yancheng; Ge, Xianglian; Yi, Tailong; Xie, Yang; Ning, Chunlan; Shen, Shengfu; Sun, Zengfeng; Zhang, Zhen; Zhai, Qiongli; Wang, Xiaoguang; Meng, Xianghui; Dong, Jun; Huang, Qiang; Yang, Xuejun; Li, Wenliang; Jin, Xun

• Polyphyllin VII as a Potential Drug for Targeting Stemness in Hepatocellular Cancer via STAT3 Signaling

  Author: Xu, Liuhang; Chen, Ziqi; Wang, Yangbin; Li, Yulin; Wang, Zhongyu; Li, Fangzhou; Xi, Xueyan

英文介绍

Current Cancer Drug Targets杂志英文介绍

Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes and genes.

Current Cancer Drug Targets publishes original research articles, letters, reviews / mini-reviews, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cancer.

As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.